Our Clinical Trials Program places participants and their families at the centre of everything we do. Our team is always here to answer questions or concerns and to ensure you feel empowered to make confident, informed decisions every step of the way.
We are currently seeking particpants with Type 2 diabetes for 2 active clinical trials: REMIT IDeglira and Lixilan One Can
We are seeking individuals with type 2 diabetes to participate in the trials, REMIT-IDegLira and Lixilan One CAN. The purpose of the REMIT-IDegLira study is to learn more about early diabetes and whether it can be reversed or put into ‘remission’.
The purpose of the Lixilan One CAN study is to evaluate the efficacy and safety of using a simple daily titration (daily dose adjustment) of the study drug compared to weekly titration (weekly dose adjustment).